BIOX Stock Analysis: Buy, Sell, or Hold?
BIOX - Bioceres Crop Solutions Corp. Ordinary Shares
$0.37
-0.02 (-5.48%)
▼
5d:
-12.28%
30d:
-11.24%
90d:
-4.38%
HOLD
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Sep 09, 2026
Get Alerted When BIOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BIOX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BIOX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: BIOX is currently trading at $0.37, which is considered oversold relative to its 30-day fair value range of $0.41 to $0.45. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.5) compared to its historical average (12.3). Remarkably, the market is currently pricing in an annual earnings decline of 15.4% over the next few years. This pessimistic expectation contrasts with the company's recent 34.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BIOX is in a downtrend. The price is currently testing key support at $0.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: BIOX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+436.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIOX is in a downtrend. The price is currently testing key support at $0.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: BIOX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+436.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.41 -
$0.45
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 436.3% below Wall St target ($2.00)
- CAUTION: 5-day price weakness (-12.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.45
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.37
Resistance Level
$0.46
Current Trend
Downtrend
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.46
Wall Street Target
$2.00
(+436.3%)
Revenue Growth (YoY)
-35.9%
Earnings Growth (YoY)
34.4%
Profit Margin
-96.9%
Valuation Discount vs History
-15.4% cheaper
PE vs Historical
7.5 vs 12.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.4%
(market-implied from PE analysis)
1-Year Target
$0.34
(-10%)
2-Year Target
$0.30
(-19%)
3-Year Target
$0.27
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→12)
$0.45
(+20%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 12.3
Stabilization Target:
$0.62
(+64.9%)
PE Expansion Potential:
+64.9%
Share & Embed Analysis
Last updated: June 21, 2026 7:55 PM ET
Data refreshes hourly during market hours. Next update: 8:55 PM
Data refreshes hourly during market hours. Next update: 8:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Agricultural Inputs Stocks
Top-rated stocks in Agricultural Inputs by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CTVA
Corteva Inc |
STRONG BUY
24 analysts |
$90 | 59 HOLD |
|
NTR
Nutrien Ltd |
STRONG BUY
24 analysts |
$82 | 57 HOLD |
|
MOS
The Mosaic Company |
BUY
20 analysts |
$27 | 58 HOLD |
|
FMC
FMC Corporation |
HOLD
20 analysts |
$17 | 51 HOLD |
|
SMG
Scotts Miracle-Gro Compa… |
STRONG BUY
11 analysts |
$73 | 56 HOLD |
